Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China

The Journal of Infection
Yunsong YuYilin Ma

Abstract

To investigate the resistance of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases (ESBLs) and the genotyping of ESBLs in China. MICs of 12 antibiotics against 50 strains (by random selection) of ESBLs-producing E. coli and K. pneumoniae were determined by E-test. The genotypes of ESBLs were analyzed by PCR, DNA sequencing and isoelectric focusing. The susceptibility rate of 50 isolates was 100% in imipenem, 60%-80% in cefoperazone/sulbactam, ceftazidime and piperacillin/tazobactam, and lower in other antimicrobial agents tested. Only 6.0% of the isolates were sensitive to cefotaxime. Four hundred and forty-seven of 509 isolates had been confirmed the genotype of ESBLs. Four hundred and sixteen strains produced only one type of ESBLs, including CTX-M-14 (271 strains), CTX-M-3 (70 strains), CTX-M-24 (35 strains), CTX-M-22 (8 strains), CTX-M-15 (4 strains), CTX-M-9 (4 strains), CTX-M-28 (3 strains), CTX-M-12 (1 strain), CTX-M-13 (1 strain), CTX-M-27 (1 strain), CTX-M-29 (1 strain), SHV-12 (10 strains), SHV-5 (4 strains), SHV-2 (2 strains), and SHV-9 (1 strain). Thirty isolates carried two or three types of ESBLs, and producing CTX-M-14 and CTX-M-3 together were the most common type. The resist...Continue Reading

Citations

Sep 18, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·U-I WuY-C Chen
Aug 30, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D-S ShiM Huang
Jun 6, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Suk-Kyung LimYou-chan Bae
Jun 10, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yan QiYunsong Yu
Feb 2, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Umaer Naseer, Arnfinn Sundsfjord
Mar 8, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Wing Sze HoKwai Lin Thong
Aug 1, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Wei JiangWen Fang Huang
Aug 18, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yuanyuan DongShulin Yang
Aug 19, 2009·The Journal of Antimicrobial Chemotherapy·Peter M Hawkey, Annie M Jones
Dec 7, 2010·The Journal of Antimicrobial Chemotherapy·Yan QiYunsong Yu
Feb 23, 2012·Antimicrobial Agents and Chemotherapy·Yan-yan HuGong-xiang Chen
Nov 28, 2013·Annals of Clinical Microbiology and Antimicrobials·Lei ZhangZhiyong Zong
Dec 7, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R ZhangG-X Chen
Aug 12, 2014·International Journal of Antimicrobial Agents·Liang LiYa-Hong Liu
Dec 17, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Timothy R BorgognaDavid E Cummings
Nov 4, 2015·Frontiers in Microbiology·Xiao-Ping LiaoHong-Xia Jiang
Oct 15, 2011·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Hella Lahlaoui, Mohamed Ben Moussa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.